FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Permanent Defibrillator Electrodes
PMA: P920015
·
Supplement: S224
·
Decision Dec 17, 2018
Classifications
1
FEI Numbers
36
Registration Numbers
36
Basic Information
- Device Name
- Permanent Defibrillator Electrodes
- Trade Name
- Sprint Quattro Lead
- PMA Number
- P920015
- Supplement Number
- S224
- Device Class
- FDA Class 3
- Product Code
- NVY
- Generic Name
- Permanent defibrillator electrodes
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- December 17, 2018
- Date Received
- November 21, 2018
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Transfer an intermediate manufacturing step to fill Dexamethasone Sodium Phosphate and Dexamethasone Acetate into vials from Medtronic Energy and Component Center to the Medtronic Cardiac Rhythm Heart Failure Rice Creek Pharma Manufacturing Operations facility and to implement minor process improvements.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NVY | Permanent Defibrillator Electrodes | FDA class 3 | Unknown |